| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |